Sex-specific incidence of hepatitis B virus flares among Bcr-Abl tyrosine kinase inhibitor users in Taiwan.

Ling-Yi WangSung-Chao ChuI-Yun ChangK Arnold Chan

Published in: Pharmacoepidemiology and drug safety (2023)

Approximately 10% of HBV carriers who used Bcr-Abl TKI experienced HBV flare in Taiwan. The risk was higher in women and among patients with chronic myeloid leukemia.

Keyphrases

chronic myeloid leukemia
hepatitis b virus
liver failure
polycystic ovary syndrome
risk factors
pregnancy outcomes
pregnant women
metabolic syndrome
cervical cancer screening
tyrosine kinase